EX-10.6 6 dex106.htm AGREEMENT AND PLAN OF MERGER AGREEMENT AND PLAN OF MERGER BY AND AMONG GILEAD SCIENCES, INC., GRYPHON ACQUISITION SUB, INC., CORUS PHARMA, INC. AND RODNEY A. FERGUSON, PH.D, AS CHAIRMAN OF AND ON BEHALF OF THE STOCKHOLDER...Agreement and Plan of Merger • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionThis Agreement and Plan of Merger (this “Agreement”) is made and entered into as of April 12, 2006, by and among GILEAD SCIENCES, INC., a Delaware corporation (“Acquiror”), GRYPHON ACQUISITION SUB, INC., a Delaware corporation and wholly owned subsidiary of Acquiror (“Merger Sub”), CORUS PHARMA, INC., a Delaware corporation (the “Company”) and RODNEY A. FERGUSON, PH.D., as Chairman of and on behalf of the Stockholder Representative Committee (the “Stockholder Representative Committee”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG GILEAD SCIENCES, INC., GRYPHON ACQUISITION SUB, INC., CORUS PHARMA, INC. AND RODNEY A. FERGUSON, PH.D, AS CHAIRMAN OF AND ON BEHALF OF THE STOCKHOLDER REPRESENTATIVE COMMITTEE DATED AS OF APRIL 12, 2006Agreement and Plan of Merger • November 6th, 2006 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 6th, 2006 Company Industry JurisdictionThis Agreement and Plan of Merger (this “Agreement”) is made and entered into as of April 12, 2006, by and among GILEAD SCIENCES, INC., a Delaware corporation (“Acquiror”), GRYPHON ACQUISITION SUB, INC., a Delaware corporation and wholly owned subsidiary of Acquiror (“Merger Sub”), CORUS PHARMA, INC., a Delaware corporation (the “Company”) and RODNEY A. FERGUSON, PH.D., as Chairman of and on behalf of the Stockholder Representative Committee (the “Stockholder Representative Committee”).